XML 21 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEPARATION OF BAXALTA INCORPORATED
3 Months Ended
Mar. 31, 2017
Discontinued Operations And Disposal Groups [Abstract]  
SEPARATION OF BAXALTA INCORPORATED

2. SEPARATION OF BAXALTA INCORPORATED

On July 1, 2015, Baxter completed the distribution of approximately 80.5% of the outstanding common stock of Baxalta Incorporated (Baxalta) to Baxter shareholders (the Distribution). After giving effect to the Distribution, the company retained 19.5% of the outstanding common stock, or 131,902,719 shares of Baxalta (Retained Shares).  The Distribution was made to Baxter’s shareholders of record as of the close of business on June 17, 2015 (Record Date), who received one share of Baxalta common stock for each Baxter common share held as of the Record Date. As a result of the Distribution, Baxalta became an independent public company trading under the symbol “BXLT” on the New York Stock Exchange.

On June 3, 2016, Baxalta became a wholly-owned subsidiary of Shire plc (Shire) through a merger of a wholly-owned Shire subsidiary with and into Baxalta, with Baxalta as the surviving subsidiary (the Merger). References in this report to Baxalta prior to the Merger closing date refer to Baxalta as a stand-alone public company. References in this report to Baxalta subsequent to the Merger closing date refer to Baxalta as a subsidiary of Shire.

For a portion of Baxalta’s operations, the legal transfer of Baxalta’s assets and liabilities did not occur with the separation of Baxalta on July 1, 2015 due to the time required to transfer marketing authorizations and other regulatory requirements in certain countries. Under the terms of the International Commercial Operations Agreement (ICOA), Baxalta is subject to the risks and entitled to the benefits generated by these operations and assets until legal transfer; therefore, the net economic benefit and any cash collected by these entities by Baxter are transferred to Baxalta. Separation of the remaining two countries is expected to occur by 2018.

Following is a summary of the operating results of Baxalta, which have been reflected as discontinued operations for the three months ended March 31, 2017 and 2016. The assets and liabilities have been classified as held for disposition as of March 31, 2017 and December 31, 2016.

 

 

 

Three months ended

March 31,

 

(in millions)

 

2017

 

 

2016

 

Major classes of line items constituting income from

   discontinued operations before income taxes

 

 

 

 

 

 

 

 

Net sales

 

$

4

 

 

$

64

 

Cost of sales

 

 

(4

)

 

 

(59

)

Marketing and administrative expenses

 

 

(1

)

 

 

(20

)

Research and development expenses

 

 

 

 

 

 

Other income and expense items that are not major

 

 

 

 

 

 

Loss from discontinued operations before income taxes

 

 

(1

)

 

 

(15

)

Gain on disposal of discontinued operations

 

 

 

 

 

17

 

Income tax expense

 

 

 

 

 

9

 

Loss from discontinued operations, net of tax

 

$

(1

)

 

$

(7

)

 

 

 

March 31,

 

 

December 31,

 

(in millions)

 

2017

 

 

2016

 

Carrying amounts of major classes of assets included as

   part of discontinued operations

 

 

 

 

 

 

 

 

Accounts and other current receivables, net

 

$

46

 

 

$

48

 

Property, plant, and equipment, net

 

 

 

 

 

1

 

Other

 

 

 

 

 

1

 

Total assets of the disposal group

 

$

46

 

 

$

50

 

 

 

 

 

 

 

 

 

 

Carrying amounts of major classes of liabilities included as

   part of discontinued operations

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

3

 

 

$

3

 

Total liabilities of the disposal group

 

$

3

 

 

$

3

 

 

As of March 31, 2017 and December 31, 2016, Baxter recorded a liability of $43 million and $46 million, respectively, for its obligation to transfer these net assets to Baxalta. On February 1, 2016, the legal transfer of approximately $90 million of net assets was distributed to Baxalta resulting in a gain of $17 million, which is recorded within income from discontinued operations, net of tax.

Baxter and Baxalta entered into several agreements in connection with the July 1, 2015 separation, including a transition services agreement (TSA), separation and distribution agreement, manufacturing and supply agreements (MSA), tax matters agreement, an employee matters agreement, a long-term services agreement, and a shareholder’s and registration rights agreement.

Pursuant to the TSA, Baxter and Baxalta and their respective subsidiaries are providing to each other, on an interim, transitional basis, various services. Services being provided by Baxter include, among others, finance, information technology, human resources, quality supply chain and certain other administrative services. The services generally commenced on the Distribution date and are expected to terminate within 24 months (or 36 months in the case of certain information technology services) of the Distribution date. Billings by Baxter under the TSA are recorded as a reduction of the costs to provide the respective service in the applicable expense category, primarily in marketing and administrative expenses, in the condensed consolidated statements of income. In the first quarter of 2017 and 2016, the company recognized approximately $20 million and $27 million, respectively, as a reduction to marketing and administrative expenses related to the TSA.

Pursuant to the MSA, Baxalta or Baxter, as the case may be, manufactures, labels, and packages products for the other party. The terms of the agreements range in initial duration from five to 10 years. In the first quarter of 2017 and 2016, Baxter recognized approximately $6 million and $11 million, respectively, in sales to Baxalta. In addition, in the first quarter of 2017 and 2016, Baxter recognized $48 million and $45 million, respectively, in cost of sales related to purchases from Baxalta pursuant to the MSA. The cash flows associated with these agreements are included in cash flows from operations — continuing operations.

Cash outflows of $17 million and $159 million were reported in cash flows from operations – discontinued operations for the periods ending March 31, 2017 and 2016, respectively. These relate to non-assignable tenders whereby Baxter remains the seller of Baxalta products, transactions related to importation services Baxter provides in certain countries, in addition to trade payables settled post local separation on Baxalta’s behalf.